Key details
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Enrollment target
~134 participants
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated January 2026